Recall Sours Abbott’s Infant Formula Results; COVID-19 Test Sales Expected To Cool

Worldwide nutrition sales, adult as well as infant products, during Q1 dropped reported 7% to $1.89bn. US sales were $59m, well below $288m in prior-year period.

Abbott's nutrition sales, adult as well as pediatric products, during Q1 dropped reported 7% to $1.89bn as it recalled Similac and other infant formula brands. • Source: Alamy

More from Earnings

More from Business